EgsA (AraM) is a soluble, homodimeric, nickel-dependent glycerol-1-phosphate dehydrogenase of Bacillus subtilis. The purified enzyme reversibly interconverts glycerone phosphate and sn-glycerol 1-phosphate, preferentially using NAD(H), with lower catalytic efficiency using NADP(H). Its stereospecific reaction produces the glycerophosphate enantiomer used by the PcrB ether-lipid synthase. EgsA is therefore a candidate source of that precursor, but its contribution to native heptaprenylglyceryl-lipid or phosphatidylglycerol synthesis has not been established. The gene lies in the L-arabinose-inducible ara operon and is regulated by AraR and glucose, yet it is dispensable for L-arabinose utilization and no chemical role in arabinose catabolism has been demonstrated.
Definition: The chemical reactions and pathways resulting in the formation of sn-glycerol 1-phosphate, the S-configured enantiomer of glycerol phosphate.
Justification: A stereospecific G1P biosynthesis process would describe precursor formation separately from downstream lipid synthesis. Free G1P is not itself a glycerophospholipid, so absence of the specific process term does not justify assigning lipid participation without evidence. This retained proposal is a terminology suggestion, not a new annotation or a claim of measured native flux.
Parent term: organophosphate biosynthetic process
Supporting Evidence:
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0005737 cytoplasm | IEA GO_REF:0000120 | ACCEPT | Summary: EgsA is a soluble cytoplasmic enzyme; the location is correct and is as precise as the available evidence allows. Reason: Cytoplasmic localization is a qualified inference from soluble recombinant enzyme behavior and the curated UniProt localization statement (ECO:0000305), consistent with its soluble nicotinamide cofactors and glycerone-phosphate substrate. No native localization or fractionation assay was identified. The proposed downstream use of G1P by PcrB is not evidence that EgsA itself supplies that pool, and is not used to establish localization. Retain the current cytoplasm granularity without claiming a directly measured membrane-face or subcompartment location. Supporting Evidence: PMID:18558723 the purified protein forms a homodimer that reversibly reduces dihydroxyacetone file:BACSU/egsA/egsA-uniprot.txt SUBUNIT: Homodimer. |
| GO:0006650 glycerophospholipid metabolic process | IEA GO_REF:0000104 | UNDECIDED | Summary: EgsA supplies G1P in vitro, but its participation in native glycerophospholipid metabolism remains unresolved. Reason: GO:0006650 concerns glycerophosphates bearing an O-acyl, O-alkyl or O-alkenyl group; free G1P lacks those groups. A precursor-forming enzyme can participate in lipid synthesis when the pathway connection is established, but that connection must be assessed rather than assumed from the existing UniRule annotation. PMID18558723 proposes a lipid role. The author dissertation describes an araM-disruption lipoteichoic-acid ELISA and later lipid experiments with exogenous 14C-G1P, which bypasses endogenous G1P formation. Neither establishes native EgsA-to-PcrB flux. KM differences do not determine intracellular reaction direction, and the occurrence of G1P-derived lipids does not identify their source enzyme. Retain uncertainty rather than rejecting the plausible lipid role or refining it to biosynthesis without a supported connection. Supporting Evidence: PMID:18558723 the purified protein forms a homodimer that reversibly reduces dihydroxyacetone file:BACSU/egsA/egsA-source-analysis/guldan-2010-assay-scope.md External G1P bypasses its endogenous formation. |
| GO:0050492 glycerol-1-phosphate dehydrogenase [NAD(P)+] activity | IEA GO_REF:0000120 | MODIFY | Summary: Refine the valid cofactor-inclusive function to both experimentally supported cofactor-specific activities. Reason: The purified bacterial enzyme catalyzes the stereospecific reversible reaction, and curated experimental catalytic statements support both NAD(H) and NADP(H). Current GO:0106357 and GO:0106358 are is_a children of GO:0050492. Both specific claims already occur in this review and jointly preserve the scope of the true parent. They are alternative cofactor reactions, not separate half-reactions. NAD(H) is preferred under the measured conditions; the NADP(H) activity is retained as secondary without claiming native cofactor usage. Proposed replacements: glycerol-1-phosphate dehydrogenase (NAD+) activity glycerol-1-phosphate dehydrogenase (NADP+) activity Supporting Evidence: PMID:18558723 which constitutes the first identified G1PDH from bacteria, has a similar PMID:18558723 on the presence of Ni (2+) instead of Zn (2+). file:BACSU/egsA/egsA-uniprot.txt Catalyzes the NAD(P)H-dependent reduction of file:BACSU/egsA/egsA-uniprot.txt Prefers NADH over NADPH as coenzyme. file:BACSU/egsA/egsA-uniprot.txt InterPro; IPR023003; G1P_dehydrogenase_bac. file:BACSU/egsA/egsA-uniprot.txt HAMAP; MF_00497_B; G1P_dehydrogenase_B |
| GO:0106357 glycerol-1-phosphate dehydrogenase (NAD+) activity | IEA GO_REF:0000116 | ACCEPT | Summary: The preferred NAD-linked reversible activity is directly characterized; native net flux remains unmeasured. Reason: The reaction is supported by recombinant B. subtilis AraM enzymology and the experimentally curated Rhea reaction. The author thesis Table 10 reports NADH KM 16.0 µM and kcat/KM 13,800 M−1 s−1 under its assay conditions, substantially above the NADPH value. This establishes a preferred cofactor in vitro, not physiological direction or demonstrated delivery of G1P to PcrB. Retain the specific molecular activity as core. Supporting Evidence: PMID:18558723 the purified protein forms a homodimer that reversibly reduces dihydroxyacetone file:BACSU/egsA/egsA-uniprot.txt Reaction=sn-glycerol 1-phosphate + NAD(+) = dihydroxyacetone phosphate file:BACSU/egsA/egsA-uniprot.txt KM=16 uM for NADH file:BACSU/egsA/egsA-uniprot.txt Prefers NADH over NADPH as coenzyme. |
| GO:0106358 glycerol-1-phosphate dehydrogenase (NADP+) activity | IEA GO_REF:0000116 | KEEP AS NON CORE | Summary: A real but secondary cofactor usage. The enzyme does turn over with NADP(H), but NADH is the preferred coenzyme, so this is kept as non-core. Reason: The experimentally curated NADP-linked reaction is corroborated by measured NADPH-dependent catalytic efficiency in the author thesis: 108 ± 27.77 M−1 s−1, compared with 13,800 ± 830 for NADH at pH 8.2 and 45°C. Separate NADPH KM and kcat were not determined. The approximately 128-fold lower efficiency supports secondary cofactor usage, not an assertion that the activity is false. KEEP_AS_NON_CORE preserves demonstrated chemistry without claiming physiological cofactor preference, evolved dual-cofactor selection, or native flux. Supporting Evidence: file:BACSU/egsA/egsA-uniprot.txt Reaction=sn-glycerol 1-phosphate + NADP(+) = dihydroxyacetone phosphate file:BACSU/egsA/egsA-uniprot.txt Prefers NADH over NADPH as coenzyme. file:BACSU/egsA/egsA-uniprot.txt Catalyzes the NAD(P)H-dependent reduction of file:BACSU/egsA/egsA-source-analysis/guldan-2010-assay-scope.md NADPH turnover was measured, but its individual KM and kcat were not determined. |
Loading supporting content…
Download this section (compressed HTML)Q: Should GO have a process term for the formation of sn-glycerol 1-phosphate, mirroring GO:0046167 for the 3-phosphate enantiomer, or a stereochemistry-neutral glycerophosphate biosynthetic parent with the two enantiomer-specific processes as children?
Suggested experts: GO ontology editors, lipid metabolism curators
Q: When an enzyme is the only characterised source of a precursor but the flux to the downstream product has never been demonstrated, how far down the pathway should a process annotation reach? Here the choice is between a precursor-level term that does not exist and a lipid-level term that reaches past what was measured.
Suggested experts: GO Consortium biocurators
Q: Is the physiological role of bacterial G1P dehydrogenase the supply of the heptaprenylglyceryl ether-lipid backbone, the supply of the minor glycerol-1-phosphate-backbone phosphatidylglycerol, both, or something not yet connected to lipids at all?
Suggested experts: Bacterial membrane lipid biochemists
Q: What is the second, unidentified bacterial route to sn-glycerol 1-phosphate implied by archaeal-lipid synthesis in AraM-free engineered E. coli, and does B. subtilis also have it?
Suggested experts: Bacterial lipid biochemists, Synthetic biologists working on archaeal lipid engineering
Experiment: Construct a clean markerless egsA deletion and a complemented derivative, and quantify heptaprenylglycerol and acetyl-heptaprenylglycerol, free glycerophosphate enantiomer pools and the backbone chirality of phosphatidylglycerol by chiral chromatography coupled to mass spectrometry. Loss of the S-backbone species and of the ether lipid in the deletion, with restoration on complementation, would establish the flux; their persistence would show the second G1P route operates in B. subtilis as well.
Hypothesis: EgsA is the source of the sn-glycerol 1-phosphate used by PcrB and of the glycerol-1-phosphate backbone found in B. subtilis phosphatidylglycerol.
Type: targeted deletion with chiral lipidomics
Experiment: Titrate egsA expression from an inducible promoter across a range spanning the native level, and measure free G1P, G1P-backbone phosphatidylglycerol and heptaprenylglycerol at each level. A monotonic response of the lipid pools to egsA dosage would identify the dehydrogenase as the controlling step; a flat response would place control downstream.
Hypothesis: Flux through EgsA, rather than the specificity of the downstream enzymes, sets how much glycerol-1-phosphate-backbone lipid the cell makes.
Type: expression titration with metabolite and lipid quantification
Experiment: Determine the full set of steady-state kinetic constants and the apparent equilibrium position for both directions at physiological pH and nickel occupancy, and measure the intracellular glycerone phosphate, G1P, NADH and NAD+ concentrations in growing cells, so that the thermodynamic driving force in vivo can be computed rather than inferred from KM values alone.
Hypothesis: The reductive direction observed in vitro is the direction the enzyme runs in the cell.
Type: enzyme kinetics combined with intracellular metabolite quantification
Experiment: Compare wild type, an egsA deletion and an araR mutant for growth, lipoprotein N-acetylation state and envelope stress sensitivity on L-arabinose and on plant arabinan-containing substrates versus glucose, and measure ether-lipid levels in each condition. A deletion phenotype confined to arabinose growth would give the enzyme a physiological setting; its absence would indicate the operon placement is not functionally informative.
Hypothesis: Arabinose induction of egsA is physiologically meaningful, and the archaeal-type ether lipid matters under a condition the operon reports.
Type: conditional phenotyping with lipid and lipoprotein analysis
What is not known — curated, literature-grounded statements of the open unknowns (the inverse of core functions).
Gap: Whether EgsA supplies the sn-glycerol 1-phosphate used natively by PcrB or in G1P-backbone phosphatidylglycerol remains unresolved in the evidence inspected. EgsA is a characterized candidate, but precursor synthesis in vitro does not establish those fluxes.
OPEN BIOLOGY BP_DARK
What is known: Recombinant AraM reduces glycerone phosphate to G1P and catalyzes the reverse reaction. B. subtilis contains G1P-derived lipids and PcrB uses G1P, but precursor identity alone does not establish enzyme-to-lipid flux. The author thesis reports an araM-disruption LTA ELISA and later G1P-fed lipid labeling; the latter bypasses the step in question. The 2026 PlsY/PlsC paper cites prior engineered E. coli lipid synthesis without AraM, suggesting an unidentified alternative G1P source in that host, not proving an alternative mechanism in B. subtilis.
Significance: This is the join between the archaeal-type backbone chemistry and the lipids that use it, and it is the point at which any process annotation on a bacterial G1P dehydrogenase stops being a statement about a measured reaction and becomes an inference from pathway logic. It also bears on whether G1P supply or acyltransferase specificity is what limits heterochiral lipid production in bacteria.
What would resolve it: Chiral lipidomics of an egsA deletion and of a complemented strain, measuring heptaprenylglycerol, its acetylated form and the backbone chirality of phosphatidylglycerol; isotopic tracing from glycerone phosphate into those pools; and a search for the second G1P route, for example by selecting for restored archaeal-lipid synthesis in an AraM-free host.
Provenance (the field's own admissions):
Gap: Why a glycerophosphate dehydrogenase that produces a candidate lipid precursor is transcribed as part of an L-arabinose catabolic operon, and under what physiological condition that coupling matters, is unknown. No metabolic connection between the enzyme's reaction and arabinose catabolism has been identified.
OPEN BIOLOGY BP_DARK
What is known: What is established is that egsA (araM) is the fifth cistron of the araABDLMNPQ-abfA operon, the operon is induced by L-arabinose and repressed by glucose through the repressor AraR, and araM is not required for L-arabinose utilisation. The enzyme's substrates are glycerone phosphate and NAD(H), neither of which is specific to pentose catabolism. What is not established is any condition under which arabinose-induced G1P production is advantageous, and whether the arrangement is functional at all rather than a relic of genome organisation.
Significance: Regulation is often the only clue to the physiological setting of an enzyme whose product has no obvious bulk role, and this enzyme's product is a minor lipid backbone and a carrier cofactor rather than a bulk membrane component. If arabinose-induced G1P synthesis is functional, it would point to the condition in which the archaeal-type lipid matters; if it is not, it is a caution against reading the operon's name into the gene's role, which the gene symbol araM has already encouraged.
What would resolve it: Measure heptaprenylglycerol, its acetylated form and glycerophosphate enantiomer pools in wild type, an egsA deletion and an araR mutant, with and without arabinose, on plant polysaccharide and on glucose; and test whether an egsA deletion has a growth, lipoprotein acetylation or envelope-stress phenotype specifically under arabinose induction.
Provenance (the field's own admissions):
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)